SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
HIV PERSISTENCE AND REACTIVATION
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
TLR7 AGONIST GS-9620 INCREASES IMMUNE-MEDIATED CLEARANCE OF HIV-INFECTED CELLS
Jeffrey Murry
Gilead Sciences, Foster City, CA, USA
VIRAL CONTROL INDUCED BY HIVCONSV VACCINES & ROMIDEPSIN IN EARLY TREATED INDIVIDUALS
Beatriz Mothe
IrsiCaixa-HIVACAT, Hospital Germans Trias i Pujol, Badalona, Spain
NO EVIDENCE OF ONGOING HIV REPLICATION AFTER 7 YEARS ON ART
Mary F Kearney
National Cancer Institute, National Institutes of Health, Frederick, MD, USA
A PROPORTION OF LATENT HIV IS MISSED BY ASSAYING ONLY RESTING CD4 T CELLS
Michele Sobolewski
University of Pittsburgh, Pittsburgh, PA, USA
CTLS PARE DEFECTIVE HIV PROVIRUSES WITHOUT IMPACTING INFECTIOUS LATENT RESERVOIRS
Szuhan Huang
George Washington University, Washington , DC, USA
DEVELOPMENT OF A PKC AGONIST DERIVED FROM INGENOL FOR HIV LATENCY DISRUPTION IN VIVO
Jessica Brehm
GlaxoSmithKline, Durham, NC, USA
HIV RNA REBOUND POSTINTERRUPTION IN PERSONS SUPPRESSED IN FIEBIG I ACUTE HIV
Jintanat Ananworanich
US Military HIV Research Program, Thai Red Cross, Bethesda, MD, USA
EARLY DETECTION OF HIV REBOUND BY INNATE SENSORS POST ART INTERRUPTION
Julie Mitchell
U.S. Military HIV Research Program, Silver Spring, MD, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
